Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Modis LK"'
Autor:
Nijjar JS; GSK, Stevenage, Hertfordshire, UK., Abbott-Banner K; GSK, Brentford, Middlesex, UK., Alvarez Y; GSK, Brentford, Middlesex, UK., Aston N; GSK, Stevenage, Hertfordshire, UK., Bass D; GSK, Upper Providence, Pennsylvania, USA., Bentley JH; GSK, Brentford, Middlesex, UK., Ellis J; GSK, Stevenage, Hertfordshire, UK., Ellson C; GSK, Stevenage, Hertfordshire, UK., Emery EC; GSK, Stevenage, Hertfordshire, UK., Feeney M; GSK, Stevenage, Hertfordshire, UK., Fernando D; GSK, Cambridge, Cambridgeshire, UK., Inman D; GSK, Stevenage, Hertfordshire, UK., Kaur R; GSK, Stevenage, Hertfordshire, UK., Modis LK; GSK, Stevenage, Hertfordshire, UK., Munoz Vicente S; GSK, Stevenage, Hertfordshire, UK., Muya C; GSK, Stevenage, Hertfordshire, UK., Nistala K; GSK, Stevenage, Hertfordshire, UK., Panoilia E; GSK, Stevenage, Hertfordshire, UK., Ray R; GSK, Research Triangle Park, North Carolina, USA riju.x.ray@gsk.com., Siederer S; GSK, Stevenage, Hertfordshire, UK., Smith JE; GSK, Stevenage, Hertfordshire, UK., Weir L; GSK, Stevenage, Hertfordshire, UK., Wisniacki N; GSK, Stevenage, Hertfordshire, UK.
Publikováno v:
Annals of the rheumatic diseases [Ann Rheum Dis] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.
Autor:
Jimenez-Duran G; Immunology Network, Immunology Research Unit, GSK, Stevenage, United Kingdom.; Institute ofInfection and Immunity, Cardiff University, School of Medicine, University Hospital of Wales, Cardiff, United Kingdom., Kozole J; Discovery Analytical, Medicinal Science and Technology (MST), GSK, Philadelphia, PA, United States., Peltier-Heap R; Discovery Analytical, Medicinal Science and Technology (MST), GSK, Stevenage, United Kingdom., Dickinson ER; Discovery Analytical, Medicinal Science and Technology (MST), GSK, Stevenage, United Kingdom., Kwiatkowski CR; Discovery Analytical, Medicinal Science and Technology (MST), GSK, Philadelphia, PA, United States., Zappacosta F; Discovery Analytical, Medicinal Science and Technology (MST), GSK, Philadelphia, PA, United States., Annan RS; Discovery Analytical, Medicinal Science and Technology (MST), GSK, Philadelphia, PA, United States., Galwey NW; Research Statistics, Development Biostatistics, GSK, Stevenage, United Kingdom., Nichols EM; Immunology Research Unit, GSK, Stevenage, United Kingdom., Modis LK; Immunology Research Unit, GSK, Stevenage, United Kingdom., Triantafilou M; Immunology Network, Immunology Research Unit, GSK, Stevenage, United Kingdom.; Institute ofInfection and Immunity, Cardiff University, School of Medicine, University Hospital of Wales, Cardiff, United Kingdom., Triantafilou K; Immunology Network, Immunology Research Unit, GSK, Stevenage, United Kingdom.; Institute ofInfection and Immunity, Cardiff University, School of Medicine, University Hospital of Wales, Cardiff, United Kingdom., Booty LM; Immunology Network, Immunology Research Unit, GSK, Stevenage, United Kingdom.
Publikováno v:
Frontiers in immunology [Front Immunol] 2022 Sep 27; Vol. 13, pp. 918551. Date of Electronic Publication: 2022 Sep 27 (Print Publication: 2022).
Autor:
Perez-Sanchez C; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.; Rheumatology Service, Reina Sofia University Hospital, Maimonides Biomedical Research Institute of Córdoba, University of Cordoba, Cordoba, Spain., Barbera Betancourt A; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Lyons PA; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Zhang Z; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.; Molecular Development of the Immune System Section, Laboratory of Immune System Biology and Clinical Genomics Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Suo C; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.; Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.; Department of Paediatrics, Cambridge University Hospitals, Cambridge, UK., Lee JC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., McKinney EF; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK., Modis LK; Adaptive Immunity Research Unit, GSK, Stevenage, UK., Ellson C; Adaptive Immunity Research Unit, GSK, Stevenage, UK., Smith KGC; Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Publikováno v:
The Journal of experimental medicine [J Exp Med] 2022 May 02; Vol. 219 (5). Date of Electronic Publication: 2022 Apr 01.
Autor:
Triantafilou M; Immunology Catalyst, Immunology Network, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK. TriantafilouM@cardiff.ac.uk.; Cardiff University, Institute of Infection and Immunity, School of Medicine, University Hospital of Wales, Heath Park, Cardiff, CF14, UK. TriantafilouM@cardiff.ac.uk., Ramanjulu J; Innate Immunity Research Unit, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, PA, 19426, USA., Booty LM; Immunology Catalyst, Immunology Network, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Jimenez-Duran G; Immunology Catalyst, Immunology Network, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.; Cardiff University, Institute of Infection and Immunity, School of Medicine, University Hospital of Wales, Heath Park, Cardiff, CF14, UK., Keles H; Functional Genomics, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Saunders K; Adaptive Immunity Research Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Nevins N; Innate Immunity Research Unit, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, PA, 19426, USA., Koppe E; Immunology Catalyst, Immunology Network, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Modis LK; Adaptive Immunity Research Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK., Pesiridis GS; Innate Immunity Research Unit, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, PA, 19426, USA., Bertin J; Innate Immunity Research Unit, GlaxoSmithKline, 1250 South Collegeville Road, Collegeville, PA, 19426, USA., Triantafilou K; Immunology Catalyst, Immunology Network, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK.; Cardiff University, Institute of Infection and Immunity, School of Medicine, University Hospital of Wales, Heath Park, Cardiff, CF14, UK.
Publikováno v:
Nature communications [Nat Commun] 2022 Mar 17; Vol. 13 (1), pp. 1406. Date of Electronic Publication: 2022 Mar 17.
Autor:
Buckley CD; The Kennedy Institute of Rheumatology, University of Oxford, Oxford, UK., Chernajovsky L; The Lorna and Yuti Chernajovsky Biomedical Research Foundation, Whitstable, UK., Chernajovsky Y; The Lorna and Yuti Chernajovsky Biomedical Research Foundation, Whitstable, UK. yuti@chernajovskyfoundation.org.uk.; Queen Mary University of London, London, UK. yuti@chernajovskyfoundation.org.uk., Modis LK; Immunology Research, GSK, Stevenage, UK., O'Neill LA; School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland., Brown D; British Society for Immunology, London, UK., Connor R; Juvenile Diabetes Research Foundation, London, UK., Coutts D; Multiple Sclerosis Society, London, UK., Waterman EA; Versus Arthritis, Chesterfield, UK., Tak PP; The Lorna and Yuti Chernajovsky Biomedical Research Foundation, Whitstable, UK.; University of Cambridge, Cambridge, UK.; Candel Therapeutics, Needham, Massachusetts, USA.; Multimorbidity Steering Group, Strategic Priorities Fund, Swindon, UK.
Publikováno v:
Nature immunology [Nat Immunol] 2021 Nov; Vol. 22 (11), pp. 1344-1348.
Autor:
Triantafilou K; Immunology Catalyst, Immunology Network, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom.; Cardiff University, Institute of Infection and Immunity, School of Medicine, University hospital of Wales, Heath Park, Cardiff, United Kingdom., Ward CJK; Cardiff University, Institute of Infection and Immunity, School of Medicine, University hospital of Wales, Heath Park, Cardiff, United Kingdom., Czubala M; Cardiff University, Institute of Infection and Immunity, School of Medicine, University hospital of Wales, Heath Park, Cardiff, United Kingdom., Ferris RG; ViiV Healthcare, Research Triangle Park, North Carolina, United States of America., Koppe E; Immunology Catalyst, Immunology Network, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom., Haffner C; Medicinal Chemistry, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom., Piguet V; Cardiff University, Institute of Infection and Immunity, School of Medicine, University hospital of Wales, Heath Park, Cardiff, United Kingdom.; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada.; Division of Dermatology, Women's College Hospital, Toronto, Canada., Patel VK; Medicinal Chemistry, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom., Amrine-Madsen H; ViiV Healthcare, Research Triangle Park, North Carolina, United States of America., Modis LK; Immunology Catalyst, Immunology Network, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom., Masters SL; Immunology Catalyst, Immunology Network, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom.; Inflammation Division, The Walter and Eliza Hall Institute, Victoria, Australia., Triantafilou M; Immunology Catalyst, Immunology Network, GlaxoSmithKline, Stevenage, Hertfordshire, United Kingdom.; Cardiff University, Institute of Infection and Immunity, School of Medicine, University hospital of Wales, Heath Park, Cardiff, United Kingdom.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2021 Apr 16; Vol. 17 (4), pp. e1009417. Date of Electronic Publication: 2021 Apr 16 (Print Publication: 2021).
Autor:
Lee KM; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia; mingchinl@unimelb.edu.au., Jarnicki A; Department of Pharmacology, The University of Melbourne, Parkville, Victoria 3050, Australia., Achuthan A; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia., Fleetwood AJ; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia., Anderson GP; Department of Pharmacology, The University of Melbourne, Parkville, Victoria 3050, Australia., Ellson C; Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, United Kingdom; and., Feeney M; Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, United Kingdom; and., Modis LK; Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, United Kingdom; and., Smith JE; Adaptive Immunity Research Unit, GlaxoSmithKline, Stevenage, Hertfordshire SG1 2NY, United Kingdom; and., Hamilton JA; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia.; Australian Institute for Musculoskeletal Science, The University of Melbourne and Western Health, St. Albans, Victoria 3021, Australia., Cook A; Department of Medicine, The Royal Melbourne Hospital, The University of Melbourne, Parkville, Victoria 3050, Australia.
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2020 Jul 01; Vol. 205 (1), pp. 213-222. Date of Electronic Publication: 2020 May 27.
Autor:
Tough DF; Epigenetics Research Unit, Oncology, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK., Rioja I; Epigenetics Research Unit, Oncology, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK., Modis LK; Adaptive Immunity Research Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK., Prinjha RK; Epigenetics Research Unit, Oncology, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK; Adaptive Immunity Research Unit, GlaxoSmithKline, Gunnels Wood Road, Stevenage, Herts, SG1 2NY, UK. Electronic address: Rabinder.Prinjha@gsk.com.
Publikováno v:
Trends in immunology [Trends Immunol] 2020 Jan; Vol. 41 (1), pp. 29-45. Date of Electronic Publication: 2019 Dec 05.
Autor:
Galván-Peña S; School of Biochemistry and Immunology, Trinity Biomedical Science Institute, Trinity College, Dublin, D2, Ireland.; Immunology Catalyst, GlaxoSmithKline, Stevenage, SG1 2NY, UK., Carroll RG; Department of Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, D2, Ireland., Newman C; In Vitro/In Vivo Translation, GlaxoSmithKline, Stevenage, SG1 2NY, UK., Hinchy EC; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, CB2 0XY, UK., Palsson-McDermott E; School of Biochemistry and Immunology, Trinity Biomedical Science Institute, Trinity College, Dublin, D2, Ireland., Robinson EK; Department of Molecular Cell and Developmental Biology, UC Santa Cruz, Santa Cruz, 95064, CA, USA., Covarrubias S; Department of Molecular Cell and Developmental Biology, UC Santa Cruz, Santa Cruz, 95064, CA, USA., Nadin A; NCE Molecular Tools Group, GlaxoSmithKline, Stevenage, SG1 2NY, UK., James AM; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, CB2 0XY, UK., Haneklaus M; School of Biochemistry and Immunology, Trinity Biomedical Science Institute, Trinity College, Dublin, D2, Ireland., Carpenter S; Department of Molecular Cell and Developmental Biology, UC Santa Cruz, Santa Cruz, 95064, CA, USA., Kelly VP; School of Biochemistry and Immunology, Trinity Biomedical Science Institute, Trinity College, Dublin, D2, Ireland., Murphy MP; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, CB2 0XY, UK., Modis LK; Immunology Catalyst, GlaxoSmithKline, Stevenage, SG1 2NY, UK., O'Neill LA; School of Biochemistry and Immunology, Trinity Biomedical Science Institute, Trinity College, Dublin, D2, Ireland. laoneill@tcd.ie.; Immunology Catalyst, GlaxoSmithKline, Stevenage, SG1 2NY, UK. laoneill@tcd.ie.
Publikováno v:
Nature communications [Nat Commun] 2019 Jan 18; Vol. 10 (1), pp. 338. Date of Electronic Publication: 2019 Jan 18.
Autor:
Carroll RG; From the School of Biochemistry and Immunology, Trinity Biomedical Science Institute, Trinity College, Dublin 2, Ireland.; the Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom., Zasłona Z; From the School of Biochemistry and Immunology, Trinity Biomedical Science Institute, Trinity College, Dublin 2, Ireland., Galván-Peña S; From the School of Biochemistry and Immunology, Trinity Biomedical Science Institute, Trinity College, Dublin 2, Ireland.; the Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom., Koppe EL; the Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom., Sévin DC; Cellzome, GlaxoSmithKline, Meyerhofstrasse 1, Heidelberg 69117, Germany., Angiari S; From the School of Biochemistry and Immunology, Trinity Biomedical Science Institute, Trinity College, Dublin 2, Ireland., Triantafilou M; the Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom.; the Institute of Infection and Immunity, School of Medicine, University Hospital of Wales, Cardiff University, Cardiff CF14 4XW, Wales, United Kingdom, and., Triantafilou K; the Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom.; the Institute of Infection and Immunity, School of Medicine, University Hospital of Wales, Cardiff University, Cardiff CF14 4XW, Wales, United Kingdom, and., Modis LK; the Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom., O'Neill LA; From the School of Biochemistry and Immunology, Trinity Biomedical Science Institute, Trinity College, Dublin 2, Ireland, laoneill@tcd.ie.; the Immunology Catalyst, GlaxoSmithKline, Gunnels Wood Road, Stevenage SG1 2NY, United Kingdom.
Publikováno v:
The Journal of biological chemistry [J Biol Chem] 2018 Apr 13; Vol. 293 (15), pp. 5509-5521. Date of Electronic Publication: 2018 Feb 20.